Zydus Lifesciences gets US FDA nod for seizure drug

Lacosamide is indicated to treat partial-onset seizures

Source: Pexels

The product will be manufactured at the group’s formulation manufacturing facility in Moraiya, Ahmedabad

Source: Pixabay

Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg, and 200 mg had annual sales of $249 mn in the United States, as per IQVIA data

Source: Unsplash